Viatris Announces Exclusive Licensing Agreement With Lexicon Pharmaceuticals For Sotagliflozin In All Markets Outside Of The U.S. And Europe

(MENAFN - PR Newswire) Continues to ExpandViatris' Innovative Portfolio in Cardiovascular Diseases LeveragesViatris' Unique Global Infrastructure and Expertise Includes Opportunities ...

By: menafn